KUALA LUMPUR, Oct 15 (Bernama) -- Align Technology Inc (Align), a global medical device company announced its Invisalign Palatal Expander System has been listed on the Singapore Medical Device Register as a class B medical device.
According to a statement, it is now commercially available in Singapore for broad patient applicability, including growing children, teens and adults (with surgery or other techniques).
Align Technology executive vice president and managing director, Asia Pacific, David Carr said the Invisalign Palatal Expander System exemplified the company’s commitment to advancing digital orthodontics with innovative solutions that enhance patient treatment experiences.
“We are excited to extend the availability of the transformative Invisalign Palatal Expander system, Align’s first direct 3D printed orthodontic appliance, to even more doctors and their patients markets across the Asia Pacific region,” he said.
The Invisalign Palatal Expander System is a modern and innovative direct 3D printed device based on proprietary and patented technology, consisting of a series of removable devices staged in small increments of movement to expand a patient’s narrow maxilla to a position determined by their treating doctor.
Invisalign Palatal Expanders are intended for use in rapid expansion and subsequent holding of skeletal and/or dental narrow maxilla (upper jaw) with primary, mixed, or permanent dentition during treatment of patients.
Combined with Invisalign First aligners, Invisalign Palatal Expanders provide doctors with a full early intervention treatment solution for Phase 1 treatment, an early interceptive orthodontic treatment for young patients.
The Invisalign Palatal Expander System is available in Australia, New Zealand, Hong Kong, and Singapore, and is expected to be available in additional Asia Pacific markets later in 2024, pending regulatory approvals.
-- BERNAMA
No comments:
Post a Comment